Laryngopharyngeal injuries after breathing tube placement during general anesthesia
Official title: Incidence,Perioperative Risk Factors and Prognosis Associated With Laryngopharyngea Injury After Endotracheal Intubation Under General Anesthesia：A Retrospective Study
Run by Zhejiang University · NCT07359586 · Data updated 2026-11-12
This project sees how often and why people who had a breathing tube during general anesthesia developed hoarseness or other throat problems after non-ear–nose–throat surgery.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 2 sites (Hangzhou, Zhejiang and 1 other locations) |
| Status | Recruiting |
| Started | November 1, 2025 |
| Main results expected | December 25, 2026 |
| Study ends | December 25, 2026 |
| Registry record updated | January 22, 2026 |
| Trial ID | NCT07359586 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients who had general anesthesia with tracheal intubation at the First Affiliated Hospital, Zhejiang University School of Medicine between October 2015 and September 2025 and required an otolaryngology consult for postoperative laryngopharyngeal complaints after non-ENT surgery.
✕Probably not a fit
Patients with preexisting laryngopharyngeal lesions, prior or postoperative tracheotomy, incomplete medical records, or multiple surgeries where the causative episode cannot be identified are unlikely to benefit from this retrospective analysis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This retrospective study reviews patients at the First Affiliated Hospital, Zhejiang University School of Medicine who underwent tracheal intubation under general anesthesia between October 1, 2015 and September 30, 2025 and later required otolaryngology consultation for laryngopharyngeal complaints. Patient data will be extracted from the anesthesia information management system and electronic medical records, and telephone follow-up will be used to document longer-term outcomes. The primary outcome is identification of risk factors for postoperative hoarseness, while secondary outcomes include the incidence and severity of vocal fold injury and factors related to prognosis. Findings will be used to characterize which perioperative practices and patient features are associated with worse throat or voice outcomes.
Why it matters
Potential benefit: If successful, the findings could help clinicians identify patients at higher risk of voice and throat injury and guide changes in intubation and perioperative care to reduce those complications.
How similar studies have gone: Prior observational studies have documented rates and some risk factors for post‑intubation hoarseness and vocal fold injury, but findings vary and additional large institutional series help refine risk estimates.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent general anesthesia with tracheal intubation at the First Affiliated Hospital of Zhejiang University School of Medicine between October 2015 and September 2025 * Patients who required otolaryngological consultation due to laryngopharyngeal complaints (including hoarseness, sore throat, cough, choking on drinking water, etc.) postoperatively * The surgical type was non-otolaryngological surgery Exclusion Criteria: * Patients with a history of laryngopharyngeal lesions (e.g., granuloma, polyp, tumour, vocal cord paralysis * Patients with a preexisting tracheotomy * Patients requiring postoperative tracheotomy * Patients with incomplete medical records * Patients who underwent multiple surgeries but for whom the specific surgical episode responsible for the laryngopharyngeal complaints could not be identified
Where it's running
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting -
he First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Completed
Study contacts
- Principal investigator: Diansan Su — First Affiliated Hospital of Zhejiang University
- Study coordinator: Diansan Su
- Email: diansansu@yahoo.com
- Phone: +8618616514088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing MGC028 in patients with advanced solid tumors
This study is testing a new treatment called MGC028 to see if it is safe and can help adults with advanced solid tumors that can't be removed or have spread.
-
Using a new imaging agent to detect various cancers
This study is testing a new imaging agent to see if it can better detect certain cancers in adults compared to standard imaging methods.
-
Liquid biopsy to differentiate types of primary liver cancer
This study is testing a new blood test to see if it can tell the difference between two types of liver cancer, hepatocellular carcinoma and intrahepatic cholangiocarcinoma, to help doctors diagnose patients more safely.
-
Testing MDX2001 for advanced solid tumors
This study is testing a new drug called MDX2001 to see if it can safely help people with advanced solid tumors like breast or colon cancer.
-
Investigating HER3-DXd for advanced solid tumors
This study is testing a new drug called HER3-DXd to see if it can safely help people with advanced solid tumors like melanoma, head and neck cancer, and gastric cancer who have already tried other treatments.
-
Treatment using CEA-targeted CAR-T cells for advanced solid tumors
This study is testing a new type of immune therapy using CAR-T cells to see if it can help people with advanced solid tumors that have a specific marker called CEA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.